Bristol-Myers Squibb to Take Part at the Wolfe Research Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Bristol-Myers Squibb (BMY) Tops Q3 EPS by 10c, Updattes FY Guidance
October 31, 2019 7:02 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $1.17, $0.10 better than the analyst estimate of $1.07. Revenue for the quarter came in at $6.01 billion versus the consensus estimate of $5.89 billion.
GUIDANCE:
Bristol-Myers Squibb sees Q4 2019 EPS of $4.25-$4.35, versus the consensus of... More
